BLOG: The Pheno-Type: Dave Kokel on Serendipity and Science, plus Zebrafish

Written by Yolandi Stanek

Dave Kokel was recently appointed as VP of Discovery Biology at BioSymetrics. He is an accomplished scientist and researcher, and recognized pioneer in phenomics-driven drug discovery. Below is an interview with Dave about what inspired him to become a scientist and his perspective on modern drug discovery, using next generation approaches to screening and experimentation.


Yolandi Stanek https://helloyo.com
Previous

BLOG: The Pheno-Type: Calum MacRae on his “hopelessly diffuse” career in science and medicine
Next

NEWS: How Will Advanced Computing Technologies Catapult Medtech Into The Future?